CenterBook Partners’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.1M Buy
142,496
+108,685
+321% +$13.1M 0.65% 27
2026
Q2
$4.51M Buy
33,811
+25,375
+301% +$2.87M 0.22% 116
2026
Q1
$939K Buy
8,436
+1,260
+18% +$149K 0.05% 366
2025
Q4
$968K Buy
+7,176
New +$783K 0.05% 377

Other funds holding ABVX

CenterBook Partners's ABVX Position: Q3 2026 in Review

CenterBook Partners increased its Abivax (ABVX) stake by 321% in Q3 2026, buying an estimated $13.1M and bringing the position to 142,496 shares worth $14.1M. The position accounts for 0.65% of the portfolio, ranked #27.

CenterBook Partners first reported a position in ABVX in Q4 2025 and has held it in 4 quarters since. 65 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • CenterBook Partners held 142,496 shares of Abivax worth $14.1M as of Q3 2026.
  • CenterBook Partners bought 108,685 Abivax shares in Q3 2026, an estimated $13.1M.
  • Abivax made up 0.65% of CenterBook Partners's portfolio in Q3 2026, its #27 holding.
  • CenterBook Partners first reported a position in Abivax in Q4 2025 and has held it in 4 quarters since.
  • 65 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.